These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 16403952)

  • 21. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
    Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between peroxisome proliferator-activated receptor gamma coactivator-1 alpha polymorphism and hypertension in Mongolians in Inner Mongolia.
    Su XL; Dong HR; Yan MR; Cui HW; Yang L; Han FQ
    Genet Mol Res; 2011 Dec; 10(4):3930-6. PubMed ID: 22194199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole body overexpression of PGC-1alpha has opposite effects on hepatic and muscle insulin sensitivity.
    Liang H; Balas B; Tantiwong P; Dube J; Goodpaster BH; O'Doherty RM; DeFronzo RA; Richardson A; Musi N; Ward WF
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E945-54. PubMed ID: 19208857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes.
    Hara K; Tobe K; Okada T; Kadowaki H; Akanuma Y; Ito C; Kimura S; Kadowaki T
    Diabetologia; 2002 May; 45(5):740-3. PubMed ID: 12107756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people.
    Hui Y; Yu-Yuan L; Yu-Qiang N; Wei-Hong S; Yan-Lei D; Xiao-Bo L; Yong-Jian Z
    Liver Int; 2008 Mar; 28(3):385-92. PubMed ID: 17999673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Gly482Ser variant in the peroxisome proliferator-activated receptor gamma coactivator-1 is not associated with diabetes-related traits in non-diabetic German and Dutch populations.
    Stumvoll M; Fritsche A; t'Hart LM; Machann J; Thamer C; Tschritter O; Van Haeften TW; Jacob S; Dekker JM; Maassen JA; Machicao F; Schick F; Heine RJ; Häring H
    Exp Clin Endocrinol Diabetes; 2004 May; 112(5):253-7. PubMed ID: 15146371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention.
    Stefan N; Thamer C; Staiger H; Machicao F; Machann J; Schick F; Venter C; Niess A; Laakso M; Fritsche A; Häring HU
    J Clin Endocrinol Metab; 2007 May; 92(5):1827-33. PubMed ID: 17327385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peroxisome proliferator-activated receptor-gamma co-activator-1alpha (PGC-1alpha) gene polymorphisms and their relationship to Type 2 diabetes in Asian Indians.
    Vimaleswaran KS; Radha V; Ghosh S; Majumder PP; Deepa R; Babu HN; Rao MR; Mohan V
    Diabet Med; 2005 Nov; 22(11):1516-21. PubMed ID: 16241916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gly482Ser polymorphism in the peroxisome proliferator-activated receptor gamma coactivator-1alpha gene is associated with oxidative stress and abdominal obesity.
    Weng SW; Lin TK; Wang PW; Chen IY; Lee HC; Chen SD; Chuang YC; Liou CW
    Metabolism; 2010 Apr; 59(4):581-6. PubMed ID: 19913841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on the relationship between polymorphisms of peroxisome proliferators-activated receptor-gamma coactivator-1alpha gene and type 2 diabetes in Shanghai Hans in China].
    Wang YB; Yu YC; Li Z; Wang C; Wang JY; Wu GT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):453-6. PubMed ID: 16086291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes.
    Barroso I; Luan J; Sandhu MS; Franks PW; Crowley V; Schafer AJ; O'Rahilly S; Wareham NJ
    Diabetologia; 2006 Mar; 49(3):501-5. PubMed ID: 16435105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men.
    Ridderstråle M; Johansson LE; Rastam L; Lindblad U
    Diabetologia; 2006 Mar; 49(3):496-500. PubMed ID: 16474966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between PGC-1alpha gene polymorphisms and type 2 diabetes risk: a case-control study of an Iranian population.
    Shokouhi S; Haghani K; Borji P; Bakhtiyari S
    Can J Diabetes; 2015 Feb; 39(1):65-72. PubMed ID: 25282005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.
    Ek J; Andersen G; Urhammer SA; Gaede PH; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
    Diabetologia; 2001 Dec; 44(12):2220-6. PubMed ID: 11793024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whites.
    Andersen G; Wegner L; Jensen DP; Glümer C; Tarnow L; Drivsholm T; Poulsen P; Hansen SK; Nielsen EM; Ek J; Mouritzen P; Vaag A; Parving HH; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
    Hypertension; 2005 Apr; 45(4):565-70. PubMed ID: 15738346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not.
    Petrovic MG; Kunej T; Peterlin B; Dovc P; Petrovic D
    Diabetes Metab Res Rev; 2005; 21(5):470-4. PubMed ID: 15782399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PGC-1alpha and exercise: important partners in combating insulin resistance.
    Russell AP
    Curr Diabetes Rev; 2005 May; 1(2):175-81. PubMed ID: 18220593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in soleus muscle gene expression associated with a metabolic endpoint following exercise training by lean and obese Zucker rats.
    Ort T; Gerwien R; Lindborg KA; Diehl CJ; Lemieux AM; Eisen A; Henriksen EJ
    Physiol Genomics; 2007 May; 29(3):302-11. PubMed ID: 17284668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymorphisms of the peroxisome proliferator-activated receptor-γ (rs1801282) and its coactivator-1 (rs8192673) are associated with obesity indexes in subjects with type 2 diabetes mellitus.
    Kruzliak P; Haley AP; Starcevic JN; Gaspar L; Petrovic D
    Cardiovasc Diabetol; 2015 Apr; 14():42. PubMed ID: 25928419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peroxisome proliferator-activated receptor gamma and its coactivator-1 alpha may be associated with features of the metabolic syndrome in adolescents.
    Sookoian S; García SI; Porto PI; Dieuzeide G; González CD; Pirola CJ
    J Mol Endocrinol; 2005 Oct; 35(2):373-80. PubMed ID: 16216916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.